|
Inspire Pharmaceuticals, Inc. Stage: Growth
Web Site : http://www.inspirepharm.com Stock Symbol : Nasdaq: ISP |
 |
Inspire Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing new treatments for diseases in the ophthalmic and respiratory/allergy areas. In July 2007, Warburg Pincus invested $75 million in Inspire. Founded in 1993 and publicly traded since 2000, Inspire currently markets three ophthalmology products and is developing products for dry eye, cystic fibrosis, allergic rhinitis and glaucoma. Warburg Pincus holds one seat on Inspire’s Board of Directors.
